Mycophenolate Mofetil and Pulmonary Fibrosis After Kidney Transplantation: A Case Report

Patient: Male, 50 Final Diagnosis: Pulmonary fibrosis Symptoms: Short of breath Medication: — Clinical Procedure: — Specialty: Transplantology Objective: Adverse events of drug therapy Background: Mycophenolate mofetil (MMF) induced lung disease has been described in only a few isolated reports. We report a case of fatal respiratory failure associated with MMF after kidney transplantation. Case Report: A 50-year-old Hispanic male with a history of end-stage renal disease secondary to hypertension underwent deceased donor kidney transplantation. His preoperative evaluations were normal except for a chest x-ray which showed bilateral interstitial opacities. Tacrolimus and MMF were started on the day of surgery. His postoperative course was uneventful and he was discharged on postoperative day 5. One month later, he presented with shortness of breath and a cough with blood-tinged sputum. His respiratory condition deteriorated rapidly, requiring intubation. Chest computer tomography (CT) demonstrated patchy ground-glass opacities with interlobular septal thickening. Comprehensive pulmonary, cardiac, infectious, and immunological evaluations were all negative. Open lung biopsy revealed extensive pulmonary fibrosis with no evidence of infection. He temporarily improved after discontinuation of tacrolimus and MMF, however, on resuming MMF his respiratory status deteriorated again and he subsequently died from hypoxic respiratory failure. Conclusions: An awareness of pulmonary lung disease due to MMF is important to prevent adverse outcomes after organ transplantation. MMF must be used with utmost care in recipients with underlying lung disease as their pulmonary condition might make them more susceptible to any harmful effects of MMF.

[1]  S. Inokuma,et al.  Characteristic features of tacrolimus-induced lung disease in rheumatoid arthritis patients , 2016, Clinical Rheumatology.

[2]  O. Georgiev,et al.  Risk factors for lung diseases after renal transplantation , 2015, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[3]  M. Haberal,et al.  Acute Respiratory Failure in Renal Transplant Recipients: A Single Intensive Care Unit Experience. , 2015, Experimental and Clinical Transplantation.

[4]  P. Zeyneloğlu Respiratory complications after solid-organ transplantation. , 2015, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

[5]  O. Georgiev,et al.  Pulmonary Complications as a Cause of Death after Renal Transplantation , 2014 .

[6]  M. Fiel-Gan,et al.  Pulmonary hemorrhage with capillaritis secondary to mycophenolate mofetil in a heart-transplant patient. , 2013, Archives of pathology & laboratory medicine.

[7]  R. D. du Bois,et al.  Mycophenolate Mofetil Improves Lung Function in Connective Tissue Disease-associated Interstitial Lung Disease , 2013, The Journal of Rheumatology.

[8]  D. Benoit,et al.  Fatal Acute Pulmonary Injury Associated with Everolimus , 2012, The Annals of pharmacotherapy.

[9]  V. Shah,et al.  Anti-thymocyte globulin induced non-cardiogenic pulmonary edema during renal transplantation , 2011, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.

[10]  N. Miyasaka,et al.  Tacrolimus-induced pulmonary injury in rheumatoid arthritis patients. , 2011, Pulmonary pharmacology & therapeutics.

[11]  S. Harper,et al.  Hypogammaglobulinemia and bronchiectasis in mycophenolate mofetil‐treated renal transplant recipients: an emerging clinical phenomenon? , 2011, Clinical transplantation.

[12]  B. Souweine,et al.  Acute respiratory failure in kidney transplant recipients: a multicenter study , 2011, Critical care.

[13]  M. Haberal,et al.  Pulmonary complications in renal recipients after transplantation. , 2011, Transplantation proceedings.

[14]  A. Ziogas,et al.  Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease , 2010, Clinical Rheumatology.

[15]  A. Awan,et al.  Basiliximab induced non-cardiogenic pulmonary edema in two pediatric renal transplant recipients , 2009, Pediatric Nephrology.

[16]  J. Paton,et al.  Reversible chronic pulmonary fibrosis associated with MMF in a pediatric patient: A case report , 2008, Pediatric transplantation.

[17]  D. Postma,et al.  Mycophenolate mofetil and bronchiectasis in kidney transplant patients: a possible relationship. , 2006, Transplantation.

[18]  A. Allison,et al.  Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection. , 2005, Transplantation.

[19]  H. Gritsch,et al.  SIROLIMUS-ASSOCIATED PULMONARY TOXICITY , 2004, Transplantation.

[20]  K. Cransberg,et al.  Bronchiectasis in children after renal or liver transplantation: A report of five cases , 2004, Pediatric transplantation.

[21]  J. Flynn,et al.  Non‐cardiogenic pulmonary edema during basiliximab induction in three adolescent renal transplant patients , 2003, Pediatric transplantation.

[22]  W. Braun,et al.  Pneumonitis associated with the use of mycophenolate mofetil. , 2003, Transplantation.

[23]  E. Altschuler Consideration of mycophenolate mofetil for idiopathic pulmonary fibrosis. , 2001, Medical hypotheses.

[24]  K. Ask,et al.  Drug-induced infiltrative lung disease. , 2001, The European respiratory journal. Supplement.

[25]  C. Ponticelli,et al.  Mycophenolate mofetil and cough. , 1998, Transplantation.

[26]  A. Monaco,et al.  Pulmonary fibrosis secondary to administration of mycophenolate mofetil. , 1998, Transplantation.

[27]  T. Sasaki,et al.  Acute respiratory failure and pulmonary fibrosis secondary to administration of mycophenolate mofetil. , 1997, Transplantation.

[28]  A. Tsaroucha,et al.  Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings. , 1997, Transplant immunology.

[29]  D. Weisenburger Interstitial pneumonitis associated with azathioprine therapy. , 1978, American journal of clinical pathology.

[30]  R. Baker,et al.  Diffuse Alveolar haemorrhage: a fatal complication after alemtuzumab induction therapy in renal transplantation. , 2015, Transplantation proceedings.

[31]  C. Collis Lung damage from cytotoxic drugs , 2004, Cancer Chemotherapy and Pharmacology.